Protara Therapeutics (TARA) EBITDA Margin (2014)

Protara Therapeutics' (TARA) quarterly EBITDA Margin came in at 4.62% in Q3 2014.

Protara Therapeutics (TARA) EBITDA Margin (2014) Analysis & Trends

Protara Therapeutics (TARA) has 1 years of EBITDA Margin data on file, last reported at 4.62% in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	16.51%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	38.10%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	17.83%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	31.68%
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Protara Therapeutics	2.25 Mn	2.25 Mn	-	-

Download Data

Date	Value
Sep 30, 2014	4.62%